Thermo Fisher Scientific Inc. vs Danaher Corporation
In their latest fiscal years, Thermo Fisher Scientific Inc. reported revenue of $44.56B and Danaher Corporation reported $24.57B — TMO was 1.8× larger by revenue. Net income was $6.70B for TMO and $3.61B for DHR.
| Latest fiscal year | TMO · FY ended Dec 2025 | DHR · FY ended Dec 2025 |
|---|---|---|
| Revenue | $44.56B | $24.57B |
| Revenue growth | +3.9% | +2.9% |
| Operating income | $7.75B | $4.69B |
| Net income | $6.70B | $3.61B |
| Net margin | 15.0% | 14.7% |
| Diluted EPS | $17.74 | $5.05 |
| Operating cash flow | $7.82B | $6.42B |
| Total assets | $110.34B | $83.46B |
| Shareholders' equity | $53.41B | $52.53B |
| Cash & equivalents | $9.85B | $4.62B |
Revenue over time
Go deeper
Both columns use the same XBRL concepts where possible, but companies may define revenue and other line items differently. Banks, insurers and industrial companies are not directly comparable on margins. Source: SEC EDGAR XBRL company facts. Not investment advice.